Septicaemia is associated with increased disease activity and mortality in systemic lupus erythematosus: a retrospective analysis from Taiwan

被引:5
作者
Tsai, P. H. [1 ]
Jang, S. S. [1 ]
Liou, L. B. [1 ,2 ,3 ]
机构
[1] Chang Gung Mem Hosp Linkou, Div Rheumatol Allergy & Immunol, Taoyuan, Taiwan
[2] Chang Gung Mem Hosp Keelung, Keelung, Taiwan
[3] Chang Gung Univ, Coll Med, Taoyuan, Taiwan
关键词
Mortality; septicaemia; SLEDAI-2K; systemic lupus erythematosus; SERIOUS INFECTIONS; SINGLE COHORT; RISK-FACTORS; HOSPITALIZATIONS; MANIFESTATIONS; POPULATION; MORBIDITY; SPECTRUM; ADULTS; DEATH;
D O I
10.1177/0961203319899162
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective This study aimed to investigate how septicaemia, non-septicaemia infection and the disease itself are associated with disease activity and mortality in inpatients with systemic lupus erythematosus (SLE) in Taiwan. Methods We retrospectively reviewed 1115 patients and enrolled 427 with SLE admitted for lupus flare-ups and co-morbidities. Disease activity and infection type/site were recorded and categorized according to the causes of admission and mortality into three categories, of which two were specified as follows: (a) septicaemia admissions, non-septicaemia admissions; and (b) septicaemia mortality, non-septicaemia infection mortality and non-infection mortality. The relationships between lupus flare-ups and mortality in different groups were analysed using an unpaired t-test, Mann-Whitney U-test and logistic regression. Results Septicaemia was the major cause of mortality in SLE inpatients. There were 98 (22.95%) mortality patients among all 427 SLE patients. The septicaemia admissions had higher disease activity (SLE Disease Activity Index 2000 = 13.00 +/- 7.98) than the non-septicaemia admissions (9.77 +/- 5.72; p < 0.01). The mean current SLEDAI score of the septicaemia mortality group (14.91 +/- 8.01) was higher than that of the non-septicaemia infection mortality group (10.05 +/- 5.75; p = 0.02), in spite of the similar mean earlier SLEDAI score. The risk of mortality in the septicaemia mortality group due to previous septicaemia admissions was 13.2 times (odds ratio) higher than in the non-septicaemia infection mortality group and 15.6 times higher than in the non-infection mortality group. Conclusion Septicaemia relates to increased lupus disease activity and is associated with a greater risk of mortality in the SLE patients than other causes of admission. Fewer previous septicaemia admissions decrease the risk of septicaemia mortality.
引用
收藏
页码:191 / 198
页数:8
相关论文
共 50 条
  • [31] Pneumocystis jirovecii Pneumonia in Systemic Lupus Erythematosus From Southern Taiwan
    Weng, Chia-Tse
    Liu, Ming-Fei
    Weng, Meng-Yu
    Lee, Nan-Yao
    Wang, Ming-Chang
    Lin, Wei-Chieh
    Ou, Chih-Ying
    Lai, Wu-Wei
    Hsu, Shiang-Chin
    Chao, Sheau-Chiou
    Chung, Ta-Jung
    Lee, Chung-Ta
    Shieh, Chi-Chang
    Wang, Jiu-Yao
    Wang, Chrong-Reen
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2013, 19 (05) : 252 - 258
  • [32] Mortality in patients with systemic lupus erythematosus: A meta-analysis of overall and cause-specific effects
    Lee, Young Ho
    Song, Gwan Gyu
    LUPUS, 2024, 33 (09) : 929 - 937
  • [33] Mortality Associated With Systemic Lupus Erythematosus in France Assessed by Multiple-Cause-of-Death Analysis
    Thomas, Guillemette
    Mancini, Julien
    Jourde-Chiche, Noemie
    Sarlon, Gabrielle
    Amoura, Zahir
    Harle, Jean-Robert
    Jougla, Eric
    Chiche, Laurent
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 (09) : 2503 - 2511
  • [34] Changing Patterns in Mortality and Disease Outcomes for Patients with Systemic Lupus Erythematosus
    Urowitz, Murray B.
    Gladman, Dafna D.
    Tom, Brian D. M.
    Ibanez, Dominique
    Farewell, Vernon T.
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (11) : 2152 - 2158
  • [35] Increased Proportion of CD226+ B Cells Is Associated With the Disease Activity and Prognosis of Systemic Lupus Erythematosus
    Nakano, Miki
    Ayano, Masahiro
    Kushimoto, Kazuo
    Kawano, Shotaro
    Higashioka, Kazuhiko
    Inokuchi, Shoichiro
    Mitoma, Hiroki
    Kimoto, Yasutaka
    Akahoshi, Mitsuteru
    Ono, Nobuyuki
    Arinobu, Yojiro
    Akashi, Koichi
    Horiuchi, Takahiko
    Niiro, Hiroaki
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [36] Splenectomy in systemic lupus erythematosus and autoimmune hematologic disease: a comparative analysis
    Barron, Nahim
    Arenas-Osuna, Jesus
    Medina, Gabriela
    Pilar Cruz-Dominguez, Maria
    Gonzalez-Romero, Fernando
    Arturo Velasques-Garcia, Jose
    Alonso Ayala-Lopez, Ernesto
    Jara, Luis J.
    CLINICAL RHEUMATOLOGY, 2018, 37 (04) : 943 - 948
  • [37] In-hospital mortality and associated factors in patients with systemic lupus erythematosus: analysis over more than 11 years in a reference hospital center
    Arrucha-Cozaya, Michelle
    Zamora-Zuniga, Nuria Cecilia
    Miranda-Hernandez, Dafhne
    Bustamante-Gonzalez, Reyna
    Martinez-Diaz, Gabriela
    Tovar-Rodriguez, Drusila
    Lopez-Zamora, Berenice
    Cruz-Dominguez, Maria Del Pilar
    Gracia-Ramos, Abraham Edgar
    Saavedra, Miguel Angel
    RHEUMATOLOGY INTERNATIONAL, 2023, 43 (12) : 2221 - 2231
  • [38] Mortality Profile Related to Systemic Lupus Erythematosus: A Multiple Cause-of-death Analysis
    Souza, Deborah C. C.
    Santo, Augusto H.
    Sato, Emilia I.
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (03) : 496 - 503
  • [39] Pragmatic Analysis of Longitudinal Data on Disease Activity in Systemic Lupus Erythematosus
    Allen, E. J.
    Farewell, Vernon T.
    COMMUNICATIONS IN STATISTICS-THEORY AND METHODS, 2009, 38 (18) : 3369 - 3388
  • [40] Carotid subclinical atherosclerosis is associated with disease activity but not vitamin D in Korean systemic lupus erythematosus
    Jung, J-Y
    Koh, B-R
    Bae, C-B
    Kim, H-A
    Suh, C-H
    LUPUS, 2014, 23 (14) : 1517 - 1522